CVS Health reported stronger-than-expected second quarter earnings on Thursday, driven by a recovery in its Aetna insurance ...

CVS Health topped Wall Street expectations for the second quarter and it's hiking its full-year forecast again, as the health ...

CVS Health Corporation (NYSE: CVS) has released its financial results for the second quarter of 2025, showcasing a robust ...

CVS Health raised its annual profit forecast after beating quarterly estimates on Thursday, as tight oversight of higher ...

The Covid-19 pandemic turned Moderna and BioNTech into household names almost overnight. Now the two companies find ...

If you’ve been cruising through CVS Pharmacy to stock up on everyday items, you might want to rethink your next shopping run.

Eli Lilly said it believes the new data bolsters the case for Mounjaro to be prescribers’ first choice for patients with Type 2 diabetes.